Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Vision Holdings (EYE) Cash & Equivalents (2016 - 2026)

National Vision Holdings (EYE) has disclosed Cash & Equivalents for 11 consecutive years, with $38.7 million as the latest value for Q1 2026.

  • Quarterly Cash & Equivalents fell 47.66% to $38.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $38.7 million through Jan 2026, down 47.66% year-over-year, with the annual reading at $38.7 million for FY2026, 47.66% down from the prior year.
  • Cash & Equivalents hit $38.7 million in Q1 2026 for National Vision Holdings, down from $56.0 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $314.6 million in Q2 2022 to a low of $38.7 million in Q1 2026.
  • Historically, Cash & Equivalents has averaged $175.8 million across 5 years, with a median of $179.5 million in 2024.
  • Biggest five-year swings in Cash & Equivalents: grew 3.75% in 2023 and later tumbled 73.0% in 2025.
  • Year by year, Cash & Equivalents stood at $230.6 million in 2022, then crashed by 35.0% to $149.9 million in 2023, then crashed by 50.67% to $73.9 million in 2024, then dropped by 24.23% to $56.0 million in 2025, then plummeted by 30.92% to $38.7 million in 2026.
  • Business Quant data shows Cash & Equivalents for EYE at $38.7 million in Q1 2026, $56.0 million in Q3 2025, and $48.5 million in Q2 2025.